Innoviva, Inc.
INVA
$20.86
-$0.12-0.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.51% | 45.53% | 80.82% | 63.34% | 61.38% |
| Total Other Revenue | -0.52% | -0.26% | 0.30% | 1.21% | 9.59% |
| Total Revenue | 10.14% | 12.02% | 18.70% | 15.54% | 21.46% |
| Cost of Revenue | 2.32% | -24.15% | -42.30% | -58.39% | -16.05% |
| Gross Profit | 11.71% | 20.20% | 38.52% | 48.25% | 33.38% |
| SG&A Expenses | 1.73% | -1.43% | 3.59% | 17.81% | 31.71% |
| Depreciation & Amortization | 0.97% | 0.55% | 6.22% | 18.90% | 33.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.05% | 5.68% | -1.81% | -3.77% | -1.38% |
| Operating Income | -2.54% | 19.59% | 49.45% | 45.42% | 57.25% |
| Income Before Tax | 111.81% | -57.15% | -123.39% | -80.74% | 8.34% |
| Income Tax Expenses | 213.59% | 255.20% | -19.73% | -2.64% | -49.25% |
| Earnings from Continuing Operations | 97.15% | -73.42% | -132.93% | -86.98% | 29.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.15% | -73.42% | -132.93% | -86.98% | 29.50% |
| EBIT | -2.54% | 19.59% | 49.45% | 45.42% | 57.25% |
| EBITDA | -2.10% | 16.78% | 42.32% | 41.40% | 53.82% |
| EPS Basic | 88.04% | -72.73% | -133.73% | -86.70% | 23.55% |
| Normalized Basic EPS | 1.19% | 27.32% | 60.36% | 56.83% | 74.80% |
| EPS Diluted | 102.46% | -79.99% | -144.74% | -90.46% | 55.69% |
| Normalized Diluted EPS | -6.82% | 30.64% | 86.28% | 71.95% | 74.04% |
| Average Basic Shares Outstanding | 2.09% | -1.42% | -2.63% | -4.16% | -5.88% |
| Average Diluted Shares Outstanding | 7.23% | -7.51% | -15.19% | -9.87% | -5.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |